Get the Stockscreener App
6.00
3.45%
0.20
After Hours:
5.98
-0.02
-0.33%
Eton Pharmaceuticals Inc stock is traded at $6.00, with a volume of 164.91K.
It is up +3.45% in the last 24 hours and up +30.43% over the past month.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
See More
Previous Close:
$5.80
Open:
$5.73
24h Volume:
164.91K
Relative Volume:
1.85
Market Cap:
$149.85M
Revenue:
$32.83M
Net Income/Loss:
$2.23M
P/E Ratio:
-25.00
EPS:
-0.24
Net Cash Flow:
$9.27M
1W Performance:
+2.92%
1M Performance:
+30.43%
6M Performance:
+60.00%
1Y Performance:
+43.88%
1-Day Range:
$5.72
$6.25
1-Week Range:
$5.40
$6.25
52-Week Range:
$3.03
$6.25
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Name
Eton Pharmaceuticals Inc
Sector
Phone
(847) 787-7361
Address
21925 W. FIELD PARKWAY, DEER PARK, IL
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Jan-04-21 | Reiterated | H.C. Wainwright | Buy |
| Sep-20-19 | Initiated | B. Riley FBR | Buy |
| Jun-10-19 | Initiated | H.C. Wainwright | Buy |
Eton Pharmaceuticals Inc Stock (ETON) Latest News
Acadian Asset Management LLC Has $395,000 Stock Holdings in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
Thompson Siegel & Walmsley LLC Takes $420,000 Position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - MarketBeat
Eton Pharmaceuticals stock hits 52-week high at $5.26 - Investing.com
Opaleye Management Inc. buys Eton Pharmaceuticals shares worth over $500k - Investing.com India
Opaleye Management Inc. buys Eton Pharmaceuticals shares worth over $500k - Investing.com
After Leaping 26% Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Shares Are Not Flying Under The Radar - Simply Wall St
Equities Analysts Offer Predictions for Eton Pharmaceuticals, Inc.’s Q3 2024 Earnings (NASDAQ:ETON) - Defense World
Equities Analysts Offer Predictions for Eton Pharmaceuticals, Inc.'s Q3 2024 Earnings (NASDAQ:ETON) - MarketBeat
Analyzing Fulcrum Therapeutics (NASDAQ:FULC) and Eton Pharmaceuticals (NASDAQ:ETON) - Defense World
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Expected to Post FY2025 Earnings of $0.31 Per Share - Defense World
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) to Post FY2025 Earnings of $0.31 Per Share, HC Wainwright Forecasts - MarketBeat
Eton Pharmaceuticals’ (ETON) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Eton Pharmaceuticals (NASDAQ:ETON) Earns Buy Rating from HC Wainwright - MarketBeat
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Short Interest Down 7.4% in August - Defense World
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Short Interest Update - MarketBeat
Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
Eton Pharmaceuticals (NASDAQ:ETON) Trading Up 2.7% - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Trading 2.7% Higher - Defense World
Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com
Thinking about buying stock in Cellebrite DI, Milestone Pharmace - GuruFocus.com
When Will Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Breakeven? - Simply Wall St
Earnings call: Eaton Pharmaceuticals sees surge in product sales, eyes PKU market - Investing.com Australia
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q2 2024 Earnings Call Transcript - Insider Monkey
Eton Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Eton Pharmaceuticals, Inc. (ETON) Q2 2024 Earnings Call Transcript - Seeking Alpha
ETONEton Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results - GlobeNewswire
Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results - StockTitan
Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results - Yahoo Finance
Eton Pharmaceuticals And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity - Via News Agency
Eton Pharmaceuticals And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity - Via News Agency
Eton Pharmaceuticals And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity - Via News Agency
Eton Pharmaceuticals (ETON) to Release Quarterly Earnings on Thursday - MarketBeat
Eton Pharmaceuticals (ETON) Scheduled to Post Earnings on Thursday - Defense World
Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 - GlobeNewswire
Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 - ForexTV.com
Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 - StockTitan
Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 - Yahoo Finance
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Shares Purchased by Acadian Asset Management LLC - Defense World
Eton Pharmaceuticals (NASDAQ:ETON) Trading 0.3% Higher - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Trading Up 0.3% - Defense World
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update - Victoria Advocate
Eton stock gains on regulatory update (NASDAQ:ETON) - Seeking Alpha
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral - EIN News
FDA sets review date for Eton's hydrocortisone solution - Investing.com
Stocks to Watch: Eton Pharmaceuticals, Match Group, Trump Media & Technology Group - MarketWatch
Upstart holdings CTO sells shares worth over $258k - Investing.com
Eton Pharma Shares Rise After FDA Accepts New Drug Application for ET-400 - MarketWatch
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution) - WICZ
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 ... - The Bakersfield Californian
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution) - GlobeNewswire
Eton Pharmaceuticals Inc Stock (ETON) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.23%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):